During the past decade, Tongji Medical College Huazhong University of Science & Technology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tongji Medical College Huazhong University of Science & Technology" #1 sponsor was "Ascentage Pharma Group Inc." with 2 trials, followed by "GeneScience Pharmaceuticals Co., Ltd." with 2 trials sponsored, "Celgene" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Genor Biopharma Co., Ltd." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tongji Medical College Huazhong University of Science & Technology" #1 collaborator was "Beijing Children's Hospital" with 2 trials as a collaborator, "Children's Hospital of Fudan University" with 2 trials as a collaborator, "Peking University First Hospital" with 2 trials as a collaborator, "The Children's Hospital of Zhejiang University School of Medicine" with 2 trials as a collaborator and "Tongji medical college huazhong university of science & technology" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Tongji Medical College Huazhong University of Science & Technology" are "Acromegaly" (1 trials), "Atopic Dermatitis" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Tongji Medical College Huazhong University of Science & Technology" in a lesser frequency.

Most popular intervention types in "Tongji Medical College Huazhong University of Science & Technology" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "HQP1351" (2 trials), "Placebo" (2 trials), "Abemaciclib" (1 trials), "GB491+ Fulvestrant" (1 trials) and "HMPL-689" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tongji Medical College Huazhong University of Science & Technology" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tongji Medical College Huazhong University of Science & Technology". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tongji Medical College Huazhong University of Science & Technology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tongji Medical College Huazhong University of Science & Technology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".